Paper29285167
Effectiveness of C5a aptamers in a TNBS-induced colitis mouse model.
Li Z and 11 others. Exp Ther Med, 2017. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Effectiveness of C5a aptamers in a TNBS-induced colitis mouse model. Papers, record 29285167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29285167
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9549758 | Therapeutic inhibition of the complement system. | Pharmacol Rev | 1998 | https://conductscience.org/library/papers/9549758 | PubMed |
| 2 | 25650554 | Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/25650554 | PubMed |
| 3 | 12176911 | Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. | Blood | 2002 | https://conductscience.org/library/papers/12176911 | PubMed |
| 4 | 15771587 | Role of C5a in inflammatory responses. | Annu Rev Immunol | 2005 | https://conductscience.org/library/papers/15771587 | PubMed |
| 5 | 19902090 | Inhibition of thrombin activity with DNA-aptamers. | Bull Exp Biol Med | 2009 | https://conductscience.org/library/papers/19902090 | PubMed |
| 6 | 9973510 | In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. | J Immunol | 1999 | https://conductscience.org/library/papers/9973510 | PubMed |
| 7 | 24831561 | The complement system in inflammatory bowel disease. | Inflamm Bowel Dis | 2014 | https://conductscience.org/library/papers/24831561 | PubMed |
| 8 | 7568051 | Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7568051 | PubMed |
| 9 | 15660527 | Aptamers: an emerging class of therapeutics. | Annu Rev Med | 2005 | https://conductscience.org/library/papers/15660527 | PubMed |
| 10 | 20592747 | Aptamers as therapeutics. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20592747 | PubMed |
| 11 | 9087411 | A second serine protease associated with mannan-binding lectin that activates complement. | Nature | 1997 | https://conductscience.org/library/papers/9087411 | PubMed |
| 12 | 16154196 | A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. | Ophthalmology | 2005 | https://conductscience.org/library/papers/16154196 | PubMed |
| 13 | 24499275 | Complement and its receptors: new insights into human disease. | Annu Rev Immunol | 2014 | https://conductscience.org/library/papers/24499275 | PubMed |
| 14 | 10657289 | Adaptive recognition by nucleic acid aptamers. | Science | 2000 | https://conductscience.org/library/papers/10657289 | PubMed |
| 15 | 10777714 | Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. | Am J Hum Genet | 2000 | https://conductscience.org/library/papers/10777714 | PubMed |
| 16 | 25277360 | Effectiveness of sildenafil and U-74389G in a rat model of colitis. | J Surg Res | 2015 | https://conductscience.org/library/papers/25277360 | PubMed |
| 17 | 20044484 | The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20044484 | PubMed |
| 18 | 9200462 | Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. | J Immunol | 1997 | https://conductscience.org/library/papers/9200462 | PubMed |
| 19 | 14676676 | Role of C5a-C5aR interaction in sepsis. | Shock | 2004 | https://conductscience.org/library/papers/14676676 | PubMed |
| 20 | 15476920 | Complement: a unique innate immune sensor for danger signals. | Mol Immunol | 2004 | https://conductscience.org/library/papers/15476920 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 29973488 | Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. | Molecules | 2018 | https://conductscience.org/library/papers/29973488 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29285167
GET https://conductscience.org/api/papers/v1/29285167/references?page=2